House Rx is a San Francisco-based healthcare technology company that partners with specialty clinics to enable medically integrated dispensing (MID) - a model where physicians, pharmacists, nurses, and care coordinators work together as one unified team. Founded in 2021 by Flatiron Health veterans Ogi Kavazovic and Tesh Khullar, the company builds AI-enabled pharmacy management software that keeps specialty medications dispensed at the point of care, cutting average time-to-therapy from 15.5 days to 3.5 days and achieving 95% medication adherence. With $100M raised across Seed, Series A, and Series B rounds, House Rx serves 80 clinic sites, 1,000+ providers, and nearly 61,000 patients, processing approximately $1.5 billion in specialty prescriptions annually.
Ogi Kavazovic is the co-founder and CEO of House Rx, a San Francisco-based specialty pharmacy platform that enables clinical practices to dispense specialty medications directly to patients in-house. A serial operator who helped scale Opower (acquired by Oracle) and Flatiron Health (acquired by Roche), Ogi pivoted to fix a problem he kept seeing: patients leaving the doctor's office only to get lost in a broken specialty pharmacy system. House Rx has raised $100 million in total, including a $55 million Series B in November 2025, and now processes approximately $1.5 billion in specialty scripts annually across 80+ clinic sites.